12,315 reports of this reaction
9.7% of all SALICYLIC ACID reports
#3 most reported adverse reaction
ERYTHEMA is the #3 most commonly reported adverse reaction for SALICYLIC ACID, manufactured by Alchemee, LLC. There are 12,315 FDA adverse event reports linking SALICYLIC ACID to ERYTHEMA. This represents approximately 9.7% of all 126,851 adverse event reports for this drug.
SALICYLIC ACID has an overall safety score of 65 out of 100. Patients taking SALICYLIC ACID who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ERYTHEMA is moderately reported among SALICYLIC ACID users, representing a notable but not dominant share of adverse events.
In addition to erythema, the following adverse reactions have been reported for SALICYLIC ACID:
The following drugs have also been linked to erythema in FDA adverse event reports:
ERYTHEMA has been reported as an adverse event in 12,315 FDA reports for SALICYLIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ERYTHEMA accounts for approximately 9.7% of all adverse event reports for SALICYLIC ACID, making it one of the most commonly reported side effect.
If you experience erythema while taking SALICYLIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.